(Q59543506)
Statements
The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats (English)
Manuel Macías
Vidal Perez-Valero
Fernando Rodríguez de Fonseca
Francisco Javier Pavón
24 March 2007